Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2003
10/23/2003US20030198986 Differential screening of a rat hippocampus cDNA library; a cDNA species encoding a novel protein designated Hct-1 is shown to be related to cytochromes P450
10/23/2003US20030198985 Assay for nitrous oxide neurologic syndrome
10/23/2003US20030198984 Design and use of amplification oligonucleotides and nucleic acid probes to Neisseria gonorrhoeae and Neisseria meningitidis which allow detection of these organisms in test samples
10/23/2003US20030198983 Methods of genetic analysis of human genes
10/23/2003US20030198982 Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses
10/23/2003US20030198980 Heteroconfigurational polynucleotides and methods of use
10/23/2003US20030198979 Method for detecting hybridized nucleic acid with improved sensitivity
10/23/2003US20030198977 Early leukemia diagnostics using microsphere arrays
10/23/2003US20030198975 Proteins associated with cell growth, differentiation, and death
10/23/2003US20030198974 Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library: application to the detection of mycobacteria
10/23/2003US20030198973 Catalyzing reaction between the reactive moiety of a protein intermediate and a coupling reagent on a modified nucleic acid to displace said moiety and form a covalent bond; peptide nucleic acids; probes and primers
10/23/2003US20030198972 Grading of breast cancer
10/23/2003US20030198970 Genostics
10/23/2003US20030198969 Haplotypes of the TACR2 gene
10/23/2003US20030198967 Multi-functional microarrays and methods
10/23/2003US20030198966 Displacement assay for detection of small molecules
10/23/2003US20030198964 Nucleic acid separation and detection by electrophoresis with a counter-migrating high-affinity intercalating dye
10/23/2003US20030198962 Using temperature control and hydrogen bond denaturation
10/23/2003US20030198961 By measuring the level of a TIEG marker; used for therapy, diagnosis, prognosis
10/23/2003US20030198959 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
10/23/2003US20030198956 Staged assembly of nanostructures
10/23/2003US20030198954 For forensic analyses, chromosome tissue/cell/organelle-specific markers, production of expression vectors, screening and diagnosis assays
10/23/2003US20030198953 For diagnosis, treatment, and prevention of related disorders
10/23/2003US20030198952 Probe bound substrate, process for manufacturing same, probe array, method of detecting target substance, method of specifying nucleotide sequence of single-stranded nucleic acid in sample, and quantitative determination of target substance in sample
10/23/2003US20030198951 Novel methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators
10/23/2003US20030198949 Viral polypeptides that regulate or modulate apoptosis
10/23/2003US20030198947 Hepatitis virus sentinel virus I (SVI)
10/23/2003US20030198946 Hepatitis-C virus testing
10/23/2003US20030198945 Method and device for inactivating viruses
10/23/2003US20030198944 Compositions and methods for reverse transcription of nucleic acid molecules
10/23/2003US20030198943 By detection of nucleotide sequences
10/23/2003US20030198664 Encapsulation drug; screening active materials
10/23/2003US20030198650 Equine herpes viruses; hybrid nucleic acid
10/23/2003US20030198647 Rheumatic diseases; autoimmune disease
10/23/2003US20030198627 siRNA knockout assay method and constructs
10/23/2003US20030196894 Disposable sub-microliter volume biosensor with enhanced sample inlet
10/23/2003CA2824698A1 Method of identifying transmembrane protein-interacting compounds
10/23/2003CA2726356A1 Methods for detecting abnormally methylated nucleic acid in heterogeneous biological samples
10/23/2003CA2523385A1 System for quantifying blood flow in tissue with periodic updating of tissue baseline conditions
10/23/2003CA2521946A1 Method of identifying transmembrane protein-interacting compounds
10/23/2003CA2484681A1 Human papilloma virus detection with dna microarray
10/23/2003CA2482904A1 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
10/23/2003CA2482903A1 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/23/2003CA2482841A1 Method of measuring human cyp3a inducibility
10/23/2003CA2482824A1 Method for the identification of modulators of a secretase activity
10/23/2003CA2482634A1 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction
10/23/2003CA2482612A1 Use of substances for treatment of tumors
10/23/2003CA2481905A1 Mutation detection and identification
10/23/2003CA2481899A1 Method for the preparation of reagents for amplification and/or detection of nucleic acids that exhibit no significant contamination by nucleic acids
10/23/2003CA2481895A1 Methods and reagents for assaying protein kinase activity
10/23/2003CA2481784A1 Methods for lightening skin and hair
10/23/2003CA2481565A1 Method and device for inactivating viruses
10/23/2003CA2481509A1 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003CA2481508A1 G-protein coupled receptor ligands and methods
10/23/2003CA2481503A1 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
10/23/2003CA2481501A1 Monitoring blood substances using self-sampled tears
10/23/2003CA2481462A1 Heteroclitic analogs and related methods
10/23/2003CA2481417A1 Detection of polymorphisms
10/23/2003CA2481387A1 Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
10/23/2003CA2481358A1 Method for making a molecularly smooth surface
10/23/2003CA2481355A1 Hydrophobic zone device
10/23/2003CA2481339A1 Methods for targeting quadruplex dna
10/23/2003CA2481328A1 Monomeric and dimeric fluorescent protein variants and methods for making same
10/23/2003CA2481239A1 Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2
10/23/2003CA2481042A1 Mycoplasma polypeptides
10/23/2003CA2480990A1 Methods and devices for performing chemical reactions on a solid support
10/23/2003CA2480986A1 Process control based on microbiological activity
10/23/2003CA2480836A1 Method for characterising analytes
10/23/2003CA2480775A1 Immunostimulatory g,u-containing oligoribonucleotides
10/23/2003CA2480745A1 Methods for treating tweak-related conditions
10/23/2003CA2480665A1 Use of na,k-atpase a-and b-subunits in bladder cancer detection and drug screening
10/23/2003CA2480491A1 High-density lipoprotein assay device and method
10/23/2003CA2480454A1 Enhanced gene expression system
10/23/2003CA2480415A1 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003CA2480410A1 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/23/2003CA2480202A1 System and method for data analysis, manipulation, and visualization
10/23/2003CA2479835A1 An ephrin-b receptor protein involved in carcinoma
10/23/2003CA2479818A1 System and method for integrated computer-aided molecular discovery
10/23/2003CA2478398A1 Methods for identifying compounds that modulate enzymatic activity
10/23/2003CA2478395A1 Methods for identifying allosteric sites
10/23/2003CA2474486A1 Targeted chromosomal mutagenesis using zinc finger nucleases
10/22/2003EP1355159A1 Use of fragments of carbamyl phosphate synthetase I (CPS 1) for the diagnosis of inflammatory diseases and sepsis
10/22/2003EP1355157A1 FADD proteins, phosphorylated p38-MAPK and FasL as tumours markers
10/22/2003EP1355152A1 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen
10/22/2003EP1355151A2 Assessing colorectal cancer
10/22/2003EP1355150A2 Panel of nucleic acid sequences for cancer diagnosis
10/22/2003EP1355149A2 Assessing colorectal cancer
10/22/2003EP1354963A1 Method for determining the prognosis of ovarian cancer
10/22/2003EP1354962A1 Use of the slug gene or of the transcription or expression products thereof in the detection and/or treatment of cancerous cells
10/22/2003EP1354961A1 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene
10/22/2003EP1354960A1 Assay for synthesis activity of hydrolases
10/22/2003EP1354890A1 Novel polypeptide and dna thereof
10/22/2003EP1354208A2 Methods of diagnosis and treatment of osteoporosis
10/22/2003EP1354201A2 Peptide biosensors for anthrax protease
10/22/2003EP1354200A2 Method of screening for gpr40 ligands
10/22/2003EP1354199A2 Diagnosis and treatment of multiple sclerosis
10/22/2003EP1354196A2 Diagnostics, drug screening and treatment for cancer
10/22/2003EP1354065A2 High through-put cloning of protooncogenes
10/22/2003EP1354064A2 Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity
10/22/2003EP1354063A2 Detecting specific nucleotide sequences
1 ... 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 ... 3003